Management of primary chronic headache in the general population: the Akershus study of chronic headache

Abstract

Primary chronic headaches cause more disability and necessitate high utilization of health care. Our knowledge is based on selected populations, while information from the general population is largely lacking. An age and gender-stratified cross-sectional epidemiological survey included 30,000 persons aged 30-44 years. Respondents with self-reported chronic headache were interviewed by physicians. The International Classification of Headache Disorders was used. Of all primary chronic headache sufferers, 80% had consulted their general practitioner (GP), of these 19% had also consulted a neurologist and 4% had been hospitalized. Co-occurrence of migraine increased the probability of contact with a physician. A high Severity of Dependence Scale score increased the probability for contact with a physician. Complementary and alternative medicine (CAM) was used by 62%, most often physiotherapy, acupuncture and chiropractic. Contact with a physician increased the probability of use of CAM. Acute headache medications were taken by 87%, while only 3% used prophylactic medication. GPs manage the majority of those with primary chronic headache, 1/5 never consults a physician for their headache, while approximately 1/5 is referred to a neurologist or hospitalized. Acute headache medication was frequently overused, while prophylactic medication was rarely used. Thus, avoidance of acute headache medication overuse and increased use of prophylactic medication may improve the management of primary chronic headaches in the future.[PUBLICATION ABSTRACT]

J Headache Pain (2012) 13:113120 DOI 10.1007/s10194-011-0391-8

ORIGINAL

Management of primary chronic headache in the general population: the Akershus study of chronic headache

Espen Saxhaug Kristoffersen

Ragnhild Berling Grande Kjersti Aaseth

Christofer Lundqvist Michael Bjrn Russell

Received: 10 August 2011 / Accepted: 27 September 2011 / Published online: 13 October 2011 The Author(s) 2011. This article is published with open access at Springerlink.com

Abstract Primary chronic headaches cause more disability and necessitate high utilisation of health care. Our knowledge is based on selected populations, while information from the general population is largely lacking. An age and gender-stratied cross-sectional epidemiological survey included 30,000 persons aged 3044 years. Respondents with self-reported chronic headache were interviewed by physicians. The International Classication of Headache Disorders was used. Of all primary chronic headache sufferers, 80% had consulted their general practitioner (GP), of these 19% had also consulted a neurologist and 4% had been hospitalised. Co-occurrence of migraine increased the probability of contact with a physician. A high Severity of Dependence Scale score increased the probability for contact with a physician. Complementary and alternative medicine (CAM) was used by 62%, most often physiotherapy, acupuncture and chiropractic. Contact with a physician increased the probability of use of CAM.

Acute headache medications were taken by 87%, while only 3% used prophylactic medication. GPs manage the majority of those with primary chronic headache, 1/5 never consults a physician for their headache, while approximately 1/5 is referred to a neurologist or hospitalised. Acute headache medication was frequently overused, while prophylactic medication was rarely used. Thus, avoidance of acute headache medication overuse and increased use of prophylactic medication may improve the management of primary chronic headaches in the future.

Keywords Primary chronic headache

Chronic migraine Medication-overuse headache

Health care utilisation General population

Introduction

Headache is a common complaint in the general population. The personal burden, social impact and economic cost for both the sufferer and society are signicant [1]. The International Classication of Headache Disorders (ICHDII) divides headaches into primary and secondary forms [2]. The most common primary headaches are migraine and tension-type headaches, while other primary headaches are rare [3]. The primary headaches are usually paroxysmal, but 3% of the general population has primary chronic headache, i.e. more than 15 headache days per months [4].

Headache accounts for 4% of the general practitioners (GPs) consultations, and 24% of these are referred to specialists or hospitals [5, 6]. Headache is probably the most common reason for referral to neurologists [57]. Approximately 2030% of all new referrals to out-patients neurological departments are due to headache [5, 6, 8, 9].

E. S. Kristoffersen R. B. Grande K. Aaseth C. Lundqvist

M. B. Russell (&)

Head and Neck Research Group, Research Centre,Akershus University Hospital, 1478 Lrenskog, Oslo, Norway e-mail: [email protected]

E. S. KristoffersenGeneral Practice Research Unit, Department of General Practice, Institute of Health and Society, University of Oslo,Oslo, Norway

C. LundqvistHKH, Research Centre, Akershus University Hospital, Lrenskog, Oslo, Norway

M. B. RussellInstitute of Clinical Medicine, Akershus University Hospital, University of Oslo, Nordbyhagen, Norway

123

114 J Headache Pain (2012) 13:113120

Our aim was to investigate primary chronic headache in the general population in order to evaluate utility of health services and medication use, since this knowledge is generally lacking.

Methods

General design

This is a cross-sectional epidemiological survey. A short postal questionnaire screened for chronic headache (C15 days/last month and/or C180 days/last year). Participants with self-reported chronic headache were invited to a clinical interview, a physical and neurological examination conducted by neurological residents. The response rate of the screening questionnaire was 71% and the participation rate of the interview was 74%. Figure 1 shows a ow chart of the study. The method has been described in more detail elsewhere [4].

Setting

The study was conducted in 2005 at Akershus University Hospital, Oslo, Norway. Provision of health care in Norway is based on a decentralized model. The state is responsible for policy design, overall capacity and quality of health care and hospital services. Almost all general practices are private enterprises and their services are contract based. The GPs are reimbursed through a xed annual fee, and fees for the specic services from the

National Health Insurance and the patients. Each Norwegian citizen has through legislation the right to be on a GPs list, and it is possible to change GP twice a year. The GP is the gate keeper for referral to specialists and hospitals except in emergencies.

Participants

A random sample of 30,000 persons aged 3044 years and stratied for age and gender was drawn from the general population of eastern Akershus County, Norway. The area includes rural and urban municipalities in close proximity to Oslo.

Headache classication

The headaches were classied according to explicit diagnostic criteria of the ICHD-II and its relevant revisions, i.e. the latest update was used in relation to chronic migraine and medication overuse headache [2, 1012]. Primary chronic headache was dened as headache at least 15 days per months for at least 3 months, not secondary to a head trauma, brain tumour, etc. Those with medication overuse as dened by ICHD-II were included as primary chronic headache [2].

Physician consultation

We dened four levels of contact due to headache, i.e. none (no physician contact), primary (GP), secondary (neurologist) and tertiary (hospitalisation). A GP referral is a prerequisite for access to neurologists, while both GP and neurologist can refer to the hospital.

Complementary and alternative contacts

The complementary and alternative medicine (CAM) forms queried were acupuncture, chiropractic, homeopathy, naprapath, physiotherapy, psychologist and psycho-motor physiotherapy.

Medication use and dependency

We asked about current medication use, and excluded medication used for other pain conditions. To assess dependency like behaviour, we used the The Severity of Dependence Scale (SDS), which includes ve questions designed to measure psychological dependence (Table 1) [13]. The questions apply to the headache medication taken within the last month. Each item is scored on a 4-point scale (03), and the total maximum score is 15. The method has been described in detail elsewhere [14].

Fig. 1 Flow chart of the participation

123

J Headache Pain (2012) 13:113120 115

Table 1 The ve questions of the Severity Dependence Scale (SDS) adapted for headache medication

1 Do you think your use of headache medication was out of control? (never/almost never = 0, sometimes = 1, often = 2, always/nearly always = 3)

2 Did the prospect of missing a dose make you anxious or worried? (scoring as for question 1)

3 Did you worry about your use of your headache medication? (scoring as for question 1)

4 Did you wish you could stop? (scoring as for question 1)

5 How difcult would you nd it to stop or go without your headache medication? (not difcult = 0, quite difcult = 1, very difcult = 2, impossible = 3)

Your headache medication was in the interview replaced with the name of the individually relevant headache medication. Each item is scored on a 4-point scale (03), and the total maximum score is 15

Statistics

Data from the interviews were directly entered using SPSS Data Entry 4.0 (SPSS Inc., Chicago, IL, USA) and statistical analyses were performed using SPSS 15.00 for Windows. For descriptive data, proportions, means and condence intervals (CI) are given. Pearson v2 test was used for testing signicance of group differences for categorical data, Fishers exact test was used when appropriate. Students t test was used for numerical data. Signicance levels were set at p \ 0.05 and 95% CI were calculated. CI and probabilities are not given when n \ 5.

Ethical issues

The Regional Committee for Medical Research Ethics and the Norwegian Social Science Data Services approved the study. All participants gave informed consent.

Results

Participants and headache diagnoses

A total of 405 participants (22% men and 78% women) had primary chronic headaches. Ninety-ve percent (n = 384) had chronic tension-type headache (CTTH), 4% (n = 15) had chronic migraine (CM), and 2% had other primary chronic headache, i.e. new daily persistent headache (n = 4) and chronic cluster headache (n = 1). Forty-nine percent (n = 199) had co-occurrence of migraine and 46% (n = 185) had medication overuse. The diagnoses are not mutually exclusive.

Physician consultation pattern

Table 2 shows the physician and CAM contact pattern. Twenty percent (79/405) had never consulted their GP because of headache, while 80% (326/405) had consulted their GP. The GP referred 1/4 with primary chronic headache to neurologist and 4% had been hospitalised.

Signicantly more women than men had had contact with their GP (83 vs. 73%, p = 0.044), while referral was not inuenced by gender.

Complementary and alternative medicine

CAM was used by 62% (253/405) (Table 2). Physiotherapy, acupuncture and chiropractic were most frequently used. The use of CAM was signicantly higher among those who had consulted a physician compared to those who had not such contact (p \ 0.001). Of those who did not consult a physician 30% had used CAM to treat their headache. Signicantly more women than men had used CAM (67 vs. 48%, p = 0.002), physiotherapy being the only subgroup with a signicant difference (57% women vs. men 36%, p = 0.001).

Co-occurrence of migraine

Table 3 shows that co-occurrence of migraine as compared to no co-occurrence of migraine signicantly increased the physician contact (p \ 0.001), while referral to hospital was not signicantly different in the two groups.

The overall use of CAM was not inuenced by migraine, but signicantly more with than without cooccurrence of migraine had acupuncture and physiotherapy (p \ 0.05).

Co-occurrence of medication overuse

Medication overuse neither inuenced the consultation pattern nor CAM. However, signicantly more with than without medication overuse had co-occurrence of migraine (p = 0.001).

Use of medication

Acute medication was used by 87, and 9% used it on a daily basis. A higher proportion of participants with than without co-occurrence of migraine used acute medication (93 vs. 81%, p \ 0.001). More women than men used acute

123

116 J Headache Pain (2012) 13:113120

Table 2 Contact and treatment pattern in relation to different primary chronic headache diagnoses

CTTH without medication overuse(N = 216) % (n)

CTTH with medication overuse(N = 169) % (n)

Chronic migraine without medication overuse (N = 3) % (n)

Chronic migraine with medication overuse(N = 14) % (n)

Other primary chronic headache without medication overuse (N = 3) % (n)

Other primary chronic headache with medication overuse (N = 7) % (n)

All primary headaches (N = 405) % (n)

Contact level

None 22 (47) 17 (28) 0 (0) 14 (2) 33 (1) 14 (1) 20 (79)

Primary 78 (169) 83 (141) 100 (3) 86 (12) 67 (2) 86 (6) 80 (326)

Secondary 16 (34) 20 (33) 33 (1) 36 (5) 67 (2) 71 (5) 19 (76)

Tertiary 4 (9) 4 (7) 0 (0) 0 (0) 33 (1) 0 (0) 4 (17)

Complementary and alternative medicineAcupuncture 30 (65) 34 (58) 0 (0) 57 (8)d 67 (2) 43 (3) 33 (133)

Chiropractic 29 (62) 28 (47) 0 (0) 29 (4) 33 (1) 14 (1) 28 (113)

Homeopathy 11 (23) 10 (17) 0 (0) 14 (2) 33 (1) 29 (2) 11 (44)

Naprapath 6 (13) 4 (6) 0 (0) 0 (0) 33 (1) 0 (0) 5 (20)

Physiotherapy 50 (109) 56 (94) 0 (0) 57 (8) 33 (1) 43 (3) 52 (211)

Psychologist 2 (4) 2 (3) 0 (0) 0 (0) 33 (1) 0 (0) 2 (8)

Psychomotor physiotherapy

6 (14) 10 (17) 0 (0) 0 (0) 0 (0) 0 (0) 8 (31)

Any CAM 61 (132) 65 (110) 0 (0) 64 (9) 67 (2) 57 (4) 62 (253)

Medication use

Acute medication

75 (163)b 100 (169)a,c 100 (3) 100 (14) 100 (3) 100 (7) 87 (352)

Prophylactic medication

3 (7) 3 (5) 0 (0) 7 (1) 0 (0) 14 (1) 3 (14)

Individual diagnoses are not mutually exclusive

a p \ 0.001 for CTTH with medication overuse versus CTTH without medication overuse

b p \ 0.001 for CTTH without medication overuse versus all other primary headaches

c p \ 0.001 for CTTH with medication overuse versus all other primary headaches

d p \ 0.05 for chronic migraine with medication overuse versus all other primary headache

medication (89 vs. 79%, p = 0.009). Participants using acute medication had signicantly more physician contact than participants not using acute medication (82 vs. 18%, p = 0.035).

Simple analgesic such as paracetamol (acetaminophen) and ibuprofen were most frequently overused 62% (n = 115), followed by combination analgesics 28% (n = 51). Triptans, ergotamines, opioids and combination of acute medications were overused by 10% (n = 10). Co-occurrence of migraine did not inuence which drugs that were overused except that triptans were only overused by those with co-occurrence of migraine. Only 4% used prophylactic treatment, with significantly more use in participants with than without co-occurrence of migraine (6 vs. 2%, p = 0.03).

The SDS score was signicantly higher in those with than without physician contact [4.3 (95% CI 4.04.6) vs.3.2 (95% CI 2.63.8)], as well as in those with than without medication overuse for all levels of physician contact (Fig. 2).

Discussion

Presentation of main ndings

Our main nding is that the majority of primary chronic headache sufferers (80%) consulted their GP due to their headache, while only 20% consulted a neurologist. Cooccurrence of migraine and a high SDS score increased the physician consulting rate. The use of CAM was high (62%) and higher if a physician had been consulted than not. Prophylactic headache medication was rarely used.

Methodological considerations

The sample size was chosen to ensure adequate numbers of participants with chronic headache for the accurate descriptive statistics. The large sample and high response rates should ensure representative data from the general population.

123

J Headache Pain (2012) 13:113120 117

Table 3 Contact and treatment pattern for participants with primary chronic headaches

All primary headaches without co-occurrence of migraine(N = 206) % (n)

All primary headaches with co-occurrence of migraine (N = 199) % (n)

All primary headaches without medication overuse (N = 220) % (n)

All primary headaches with medication overuse (N = 185) % (n)

Contact level

None 28 (57) 11 (22)a 22 (48) 17 (31)

Primary 72 (149) 89 (177)a 78 (172) 83 (154) Secondary 15 (31) 23 (45)a 16 (36) 22 (40)

Tertiary 5 (10) 4 (7) 5 (10) 4 (7)

Complementary and alternative medicine

Acupuncture 28 (57) 38 (76)b 30 (67) 36 (66)

Chiropractic 26 (54) 30 (59) 29 (63) 27 (50)

Homeopathy 10 (20) 12 (24) 11 (24) 11 (20)

Naprapath 5 (10) 5 (10) 6 (14) 3 (86)

Physiotherapy 47 (97) 57 (114)b 50 (110) 55 (101)

Psychologist 2 (4) 2 (4) 2 (5) 2 (3)

Psychomotor physiotherapy

7 (14) 9 (17) 6 (14) 9 (17)

Any CAM 58 (120) 67 (133) 61 (134) 64 (119) Medication use

Acute medication

81 (167) 93 (185)a 76 (167) 100 (185)c

Prophylactic medication

1 (3) 6 (11)b 3 (7) 4 (7)

0 (0) 100 (199) 42 (92) 58 (107)c

Individual contacts and treatments are not mutually exclusive

a,b p \ 0.001 and p \ 0.05, respectively, for all primary chronic headaches with versus without migraine

c p \ 0.01 for all primary chronic headaches with versus without medication overuse

Fig. 2 Severity Dependence Scale (SDS) scores in participants with primary chronic headache with (black) or without (dashed) medication overuse versus contact level

Co-occurrence of migraine

The age range of patients of 3044 years was chosen in order to target the highest number of participants with pure primary chronic headache, as the prevalence is lower in younger people, and older people have a higher

risk of co-morbidity with other disorders. Furthermore, data from the Norwegian prescription registry indicate that the drug prescription pattern is different in people below and above 50 years of age [15].

Two neurological residents with experience in headache diagnostics conducted all interviews. The different headache diagnoses were equally frequently set by both physicians, suggesting that inter-observer variation was low. The headache diagnoses were equally frequent in participants interviewed at the clinic and in those interviewed by telephone.

Our data on medication use and health care utilisation are based on self-reports and therefore open to recall bias, although there is no reason to suspect systematic bias. Health registry data are, however, often incomplete and not necessarily more precise. In addition, registry data do not exist for a majority of treatment contacts outside traditional conventional medicine.

Physician contact

Twenty percent of the subjects with primary chronic headache had never consulted a physician due to headache.

123

118 J Headache Pain (2012) 13:113120

The reason for this is unknown, but a possible reason may be due to the low status of headache. For some people, the chronic headache may represent just a minor problem in a co-morbidity of other pain condition [5, 16]. It may also be that some of those not consulting a physician prefer CAM as a treatment option or they might manage their headache adequately by themselves and do not feel a need for further help. In a study conducted in a primary care population, 28% of those with chronic headache reported that they did not need a consultation for their headache [17]. Thus, this gure corresponds well with our gure. Eighty percent consulted their GP for their primary chronic headache, and 1/4 was referred to a neurologist. The referral rate to neurologists is quite low considering that the management of chronic headaches is a real challenge that is often not successful in primary care. Other population-based studies on chronic headache found that 4060% consulted their GP and 1328% was referred to a neurologist during the previous 612 months [1820].

In our study, 4% had been admitted to hospital in-patient treatment due to their headache. This is similar to a European general population study [18], but low compared to a US study [20]. The latter might be accounted for by medication overuse headache primarily being caused by analgesics and triptans in Europe, while barbiturates and opioids are major challenges which often require hospitalisation in medication overuse headache in USA.

Co-occurrence of migraine increased the consultation rate. Similarly, migraine caused a higher consultation rate than tension-type headache in the general Danish population [21, 22]. However, a French and an American study found the consultation rate was not inuenced by cooccurrence of migraine among those who had chronic headache [18, 20].

Use of complementary and alternative medicine

Over 60% of those with primary chronic headache had, at some point, used CAM because of their headache. Other studies have found that 4090% of chronic headache sufferers from different clinical settings use CAM for their headache [2325]. This indicates that chronic headache sufferers like other chronic pain sufferers are likely to use CAM as treatment [26, 27].

One reason for the high use of CAM despite the wide range of traditional medical treatments for headache, may be failure to achieve optimal control with medication.The use of CAM is high and increasing in Norway and worldwide [28, 29] and approximately 1/3 person in the Norwegian general population who use CAM use it because of headache [30]. A survey conducted in the UK among CAM providers conrmed that headache is one of

the conditions believed to benet mostly from different CAM subtypes [31].

Use of medication

Eighty-seven percent used any acute medication for their primary chronic headache, which is similar to the 84% found in France [18]. Forty-six percent of those with primary chronic headache overused medication, which is a high proportion compared to the 2535% found in three other population studies [19, 32, 33]. Part of this might be explained by the use of different diagnostic criteria, i.e. ICHD II versus criteria suggested by Silberstein [34, 35]. The distribution of type of overused medication is comparable to other population-based studies where simple analgesics are most frequently overused and paracetamol the main overused drug [18, 20, 33]. Paracetamol (acetaminophen) and ibuprofen are available as over-the-counter (OTC) drugs and are the most commonly used simple analgesics in Norway.

The prevalence of medication overuse may also be difcult to compare across studies using different data collection methods. The condition may, in some settings, be underreported.

The proportion of medication overuses among chronic headache sufferers in the general population are lower than that seen in headache clinics, and the spectrum of overused medication differs slightly [18, 32, 33, 3638].

In US it has been found that 23% of chronic headache used acute medication on a daily basis [20] in contrast to only 9% in the Norwegian general population. Norwegian results comparable to those from the US are only found in neurology out-patient settings [39].

The rare use of prophylactic treatment is surprising considering the diagnosis of primary chronic headache and the frequent use of acute headache medication.

The SDS was signicantly higher in those with than without medication overuse for all levels of physician contact (Fig. 2). Primary chronic headache participants in contact with physicians had signicantly higher SDS than those without such contact. Thus, our results support the hypothesis that persons with physician contact differ from those without such contact, and that people with physician contact are likely to be more severe headache sufferers with more disability, dependency-like characteristics and other headache-related problems.

To alleviate the world wide problem of medication overuse headache, it is important to educate those with medication overuse headache to reduce their medication consumption. We have previously described that a short advice can reduce the medication use considerable and this also leads to the reduction of the headache frequency [40].

123

J Headache Pain (2012) 13:113120 119

Conclusion

Primary chronic headache is most often treated by health professionals, though 1/5 never consulted a physician. Cooccurrence of migraine increases physician consultations and affects treatment level within the health care system. CAM is also a frequently used treatment option. The chronic headache spectrum seen by GPs and neurologists differs. The high degree of self-management, the high proportion of medication overuse and the frequent use of less well-documented treatment forms is a major concern. Improved management by health professionals, not least GPs, as well as increased use of prophylactic treatment and detoxication of medication overuse is likely to alleviate the burden for those with primary chronic headache. However, those patients who do not seek medical contact also deserve attention.

Acknowledgments Akershus University Hospital kindly provided research facilities. This study was supported by Grants from the East Norway and South East Norway. Regional Health Authority and Faculty Division Akershus University Hospital. ESK was supported by the University of Oslo.

Conict of interest None.

Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution and reproduction in any medium, provided the original author(s) and source are credited.

References

1. Jensen R, Stovner LJ (2008) Epidemiology and comorbidity of headache. Lancet Neurol 7:354361

2. Headache Classication Subcommittee of the International Headache Society (2004) The international classication of headache disorders, 2nd edn. Cephalalgia 24(Suppl 1):9160

3. Rasmussen BK, Jensen R, Schroll M, Olesen J (1991) Epidemiology of headache in a general populationa prevalence study. J Clin Epidemiol 44:11471157

4. Grande RB, Aaseth K, Gulbrandsen P, Lundqvist C, Russell MB (2008) Prevalence of primary chronic headache in a population-based sample of 30- to 44 year-old persons. The Akershus study of chronic headache. Neuroepidemiology 30:7683

5. Ridsdale L, Clark LV, Dowson AJ, Goldstein LH, Jenkins L, McCrone P, Morgan M, Seed PT (2007) How do patients referred to neurologists for headache differ from those managed in primary care? Br J Gen Pract 57:388395

6. Latinovic R, Gulliford M, Ridsdale L (2006) Headache and migraine in primary care: consultation, prescription, and referral rates in a large population. J Neurol Neurosurg Psychiatry 77:385387

7. Cockerell OC, Goodridge DM, Brodie D, Sander JW, Shorvon SD (1996) Neurological disease in a dened population: the results of a pilot study in two general practices. Neuroepidemiology 15:7382

8. Wiles CM, Lindsay M (1996) General practice referrals to a department of neurology. J R Coll Physicians Lond 30:426431

9. Bekkelund SI, Albretsen C (2002) Evaluation of referrals from general practice to a neurological department. Fam Pract 19:297299

10. Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gbel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Steiner TJ, International Headache Society (2005) The International Classication of Headache Disorders, 2nd Edition (ICHD-II)revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 25:460465

11. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gbel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ, International Headache Society (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742746

12. Cephalalgia (2006) ERRATUM. Cephalalgia 26:36013. Gossop M, Darke S, Grifths P, Hando J, Powis B, Hall W, Strang J (1995) The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90:607614

14. Grande RB, Aaseth K, Saltyte BJ, Gulbrandsen P, Russell MB, Lundqvist C (2009) The Severity of Dependence Scale detects people with medication overuse: the Akershus study of chronic headache. J Neurol Neurosurg Psychiatry 80:784789

15. Norwegian Prescription Database (NorPD) (2011) http://www.reseptregisteret.no/

Web End =http://www. http://www.reseptregisteret.no/

Web End =reseptregisteret.no/ .Accessed 18-02-2011

16. Scher AI, Stewart WF, Lipton RB (2006) The comorbidity of headache with other pain syndromes. Headache 46:14161423

17. Coeytaux RR, Linville JC (2007) Chronic daily headache in a primary care population: prevalence and headache impact test scores. Headache 47:712

18. Lanteri-Minet M, Auray JP, El Hasnaoui A, Dartigues JF, Duru G, Henry P, Lucas C, Pradalier A, Chazot G, Gaudin AF (2003) Prevalence and description of chronic daily headache in the general population in France. Pain 102:143149

19. Lu SR, Fuh JL, Chen WT, Juang KD, Wang SJ (2001) Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 21:980986

20. Scher AI, Lipton RB, Stewart WF, Bigal ME (2010) Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia 30:321328

21. Rasmussen BK, Jensen R, Olesen J (1992) Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health 46:443446

22. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R (2005) Secular changes in health care utilization and work absence for migraine and tension-type headache: a population based study. Eur J Epidemiol 20:10071014

23. Rossi P, Di LG, Malpezzi MG, Faroni J, Cesarino F, Di Lorenzo G, Nappi G (2005) Prevalence, pattern and predictors of use of complementary and alternative medicine (CAM) in migraine patients attending a headache clinic in Italy. Cephalalgia 25:493506

24. Rossi P, Di Lorenzo G, Faroni J, Malpezzi MG, Cesarino F, Nappi G (2006) Use of complementary and alternative medicine by patients with chronic tension-type headache: results of a headache clinic survey. Headache 46:622631

25. Gaul C, Eismann R, Schmidt T, May A, Leinisch E, Wieser T, Evers S, Henkel K, Franz G, Zierz S (2009) Use of complementary and alternative medicine in patients suffering from primary headache disorders. Cephalalgia 29:10691078

26. Artus M, Croft P, Lewis M (2007) The use of CAM and conventional treatments among primary care consulters with chronic musculoskeletal pain. BMC Fam Pract 8:26

123

120 J Headache Pain (2012) 13:113120

27. Rosenberg EI, Genao I, Chen I, Mechaber AJ, Wood JA, Faselis CJ, Kurz J, Menon M, ORorke J, Panda M, Pasanen M, Staton L, Calleson D, Cykert S (2008) Complementary and alternative medicine use by primary care patients with chronic pain. Pain Med 9:10651072

28. Fonnebo V, Launso L (2009) High use of complementary and alternative medicine inside and outside of the government-funded health care system in Norway. J Altern Complement Med 15:10611066

29. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC (1998) Trends in alternative medicine use in the United States, 19901997: results of a follow-up national survey. JAMA 280:15691575

30. Statistics Norway (2011) The Norwegian Health Interview Survey. http://www.ssb.no/ssp/utg/201002/05/tab-2010-05-03-03.html/

Web End =http://www.ssb.no/ssp/utg/201002/05/tab-2010-05-03-03.html/ . Accessed 10-03-2011

31. Long L, Huntley A, Ernst E (2001) Which complementary and alternative therapies benet which conditions? A survey of the opinions of 223 professional organizations. Complement Ther Med 9:178185

32. Castillo J, Munoz P, Guitera V, Pascual J (1999) Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache 39:190196

33. Colas R, Munoz P, Temprano R, Gomez C, Pascual J (2004) Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 62:13381342

34. Siberstein SD, Lipton RB, Solomon S, Mathew NT (1994) Classication of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 34:17

35. Silberstein SD, Lipton RB, Sliwinski M (1996) Classication of daily and near-daily headaches: eld trial of revised IHS criteria. Neurology 47:871875

36. Dowson AJ (2003) Analysis of the patients attending a specialist UK headache clinic over a 3 year period. Headache 43:1418

37. Zeeberg P, Olesen J, Jensen R (2006) Probable medication-overuse headache: the effect of a 2 month drug-free period. Neurology 66:18941898

38. Meskunas CA, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME (2006) Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15 year period. Headache 46:766772

39. Bekkelund SI, Salvesen R (2002) Drug-associated headache is unrecognized in patients treated at a neurological centre. Acta Neurol Scand 105:120123

40. Grande RB, Aaseth K,altyt_

e Bent J, Lundqvist C, Russell MB (2011) Reduction of medication-overuse headache after modied brief intervention. The Akershus study on chronic headache. Eur J Neurol 18:129137

123